Brian C. Stephenson - Nov 19, 2024 Form 4 Insider Report for BridgeBio Pharma, Inc. (BBIO)

Signature
/s/ Brian C. Stephenson
Stock symbol
BBIO
Transactions as of
Nov 19, 2024
Transactions value $
-$93,137
Form type
4
Date filed
11/20/2024, 07:57 PM
Previous filing
Nov 19, 2024
Next filing
Dec 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BBIO Common Stock Sale -$93.1K -4.16K -4.24% $22.41 93.8K Nov 19, 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 22, 2024.
F2 Represents the weighted average sale price of the shares sold ranging from $21.95 to $22.78 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.